NewsTesting Human Biology on Human DataMilad Alucozai on the launch of the National Center to Accelerate Cures, built to validate non-animal testing tools for the FDA.Read Spotlights, perspectives, news, and field notes from across the Pamir portfolio.
NewsTesting Human Biology on Human DataMilad Alucozai on the launch of the National Center to Accelerate Cures, built to validate non-animal testing tools for the FDA.Read
PerspectiveBeyond the Snapshot: Talus Bio's Ptarmigan-1An early check, a board meeting, and a model that screens trillions of compounds against the human proteome in days.Read
PerspectivePamir's Executive Breakfast in New YorkMilad Alucozai on hosting Pamir's executive breakfast in New York, and why a firm is only as strong as the people who build it.Read
NewsAt C-Path's 2026 Global Impact ConferenceMilad Alucozai opened day two of C-Path's Global Impact Conference in Washington with a fireside chat on high-fidelity data and rare disease.Read
SpotlightAstrocade and the Sadeghian BrothersMilad Alucozai on Astrocade co-founders Ali and Amir Sadeghian, and how a childhood across four continents built an unbreakable sibling trust.Read
PerspectiveRoger Ferguson on AWM Insights: a three-part conversationAcross three episodes: the arc of a career from Harvard to the Fed to TIAA, why this AI cycle is not 1999, and what actually compounds across generations.Read
PerspectiveWatching a Friend Build Something HistoricMilad Alucozai on Andy Beam, Lila Sciences and the humble curiosity behind the push for scientific superintelligence.Read
PerspectiveA Bridge From the Midwest to the BayAt the launch of the Third Coast Foundry, Milad Alucozai on why Midwest deep tech founders need high-conviction lead capital.Read
PerspectiveFind Your TablesAfter three hours of honest conversation over dinner, Milad Alucozai on why community is one of the best things a founder can invest in.Read
PerspectiveBuilding the Ladder Behind UsOver dinner with the brothers behind Webs.com and Truebill, Milad Alucozai on lessons from two exits and the responsibility that comes with them.Read
NewsMeasuring the Fatigue Patients FeelThe FDA qualified a tool to measure fatigue in rheumatoid arthritis, C-Path's sixth qualified outcome assessment. Milad Alucozai on why it matters.Read
PerspectiveBack at Creative Destruction LabMilad Alucozai returns as a mentor at Creative Destruction Lab, where founders get world-class mentorship for no fees and no equity.Read
PerspectiveBringing Stroke Care to Every PatientAt the kickoff of ARPA-H's AIR program, Milad Alucozai on autonomous robotic surgery for stroke and the patients it could reach.Read
PerspectiveWhy Every Founder Should Spend Time in the BayA UK founder moved her company to Palo Alto after one summer. Milad Alucozai on what makes the Bay Area different.Read
PerspectiveIn Service to FoundersAt a Pamir dinner of Nobel laureates, executives and founders, Milad Alucozai on why every step of his career was training for one job.Read
PerspectiveThe Promise of America, Paid ForwardReflections on America's 250th — from a young student in a segregated D.C. classroom to Vice Chairman of the Federal Reserve, and the case for a more inclusive capitalism.Read
PerspectiveAt ARK Invest's Big Ideas SummitPamir's Anand Subramanian on a week in St. Petersburg with ARK Invest — an investor panel, a dinner of founders and policymakers, and the ideas moving markets.Read
SpotlightAstrocade — $56M Series A & B Led by SequoiaTwo brothers spent four years building an AI gaming platform that ramped from zero to 140M game plays per month.Read
NewsCondor Launches Advanced Analytics & Dynamic Scenario SuiteCondor's platform now spans the full R&D financial lifecycle, adding forecasting and dynamic scenario planning for life-sciences finance teams.Read
SpotlightGreenCat — AI-Driven Catalyst DiscoveryGreenCat is transforming chemical discovery by pairing AI with autonomous labs to accelerate catalyst development.Read
SpotlightCondor Software — $24M Series A Led by Insight PartnersThe first financial intelligence platform for life sciences, unifying clinical, operational, and financial data.Read
PerspectiveReflecting on the 2026 Founders SummitPamir co-hosted the Founders Summit in Palm Beach — with Ken Langone, Bob Langer, and a community of technical founders.Read
PerspectiveThe Geopolitical Tipping PointA thesis on bio-industrial dominance through 2050 — why the nations that treat biotechnology as a sovereign industrial system, not a series of breakthroughs, will define the next half-century.Read
PerspectiveScientist to founderA conversation on the journey from theoretical science to industry, with the co-founder and Chief Scientist of GreenCat.Read
PerspectiveJPM Healthcare Breakfast 2026At JPM 2026, Pamir partners hosted a private breakfast with Norton Rose Fulbright, convening healthcare founders and investors around clinical proof and biology-native AI.Read
PerspectiveRoger Ferguson at the Milken Institute Global ConferencePamir co-founder Roger Ferguson — former Fed Vice Chair and TIAA CEO — on the economy, markets, and reading inflection points before they arrive.Read